Related Experiment Videos

Time dependent effects of medroxyprogesterone acetate on hepatic ultrastructure in rats

J H Stengård1, F Stenbäck, H U Saarni

  • 1National Public Health Institute, Helsinki, Finland.

Research Communications in Chemical Pathology and Pharmacology
|October 1, 1991
PubMed

Insights

Medroxyprogesterone acetate (MPA) treatment alters rat liver ultrastructure, increasing hepatocyte size and smooth endoplasmic reticulum volume. These changes are time-dependent and reversible after MPA cessation, suggesting hormonal or induction-related effects.

Area of Science:

  • Hepatology
  • Toxicology
  • Endocrinology

Background:

  • Medroxyprogesterone acetate (MPA) is a synthetic progestin with various therapeutic uses.
  • Understanding the potential side effects of MPA on organ systems, particularly the liver, is crucial for patient safety.

Purpose of the Study:

  • To investigate the effects of MPA treatment on the ultrastructure of rat liver cells.
  • To determine the time-dependency and reversibility of MPA-induced liver changes.

Main Methods:

  • Rats were treated with MPA daily for seven days.
  • Liver tissue was examined using light and electron microscopy.
  • Morphological changes in hepatocytes, endoplasmic reticulum, and mitochondria were quantified.

Main Results:

  • MPA treatment caused cytoplasmic vacuolization, increased hepatocyte size, and enlarged smooth endoplasmic reticulum (SER) and mitochondria.
  • A decrease in rough endoplasmic reticulum (RER) and common bleb formation were observed.
  • The most significant changes occurred after seven days of MPA administration and largely reversed within 17 days post-treatment.

Conclusions:

  • MPA significantly alters rat liver ultrastructure in a time-dependent manner.
  • The observed hepatic changes are reversible upon MPA cessation.
  • These alterations may be attributed to the induction phenomenon and/or the hormonal properties of MPA.

Related Concept Videos